Karin Hehenberger

529 total citations
9 papers, 409 citations indexed

About

Karin Hehenberger is a scholar working on Rehabilitation, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Karin Hehenberger has authored 9 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rehabilitation, 5 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Molecular Biology. Recurrent topics in Karin Hehenberger's work include Wound Healing and Treatments (6 papers), Diabetic Foot Ulcer Assessment and Management (4 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Karin Hehenberger is often cited by papers focused on Wound Healing and Treatments (6 papers), Diabetic Foot Ulcer Assessment and Management (4 papers) and Protein Kinase Regulation and GTPase Signaling (2 papers). Karin Hehenberger collaborates with scholars based in Sweden and Australia. Karin Hehenberger's co-authors include Anders Hansson, Kerstin Brismar, Johan Heilborn, Gunnar Kratz, Folke Lind, Samy M. Abdel‐Halim and Marja Thorén and has published in prestigious journals such as Clinical Journal of the American Society of Nephrology, Wound Repair and Regeneration and Journal of Dermatological Science.

In The Last Decade

Karin Hehenberger

9 papers receiving 390 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karin Hehenberger Sweden 8 235 174 72 71 57 9 409
Ariana García‐Ojalvo Cuba 11 190 0.8× 157 0.9× 89 1.2× 54 0.8× 48 0.8× 30 436
Guojuan Lao China 13 224 1.0× 154 0.9× 127 1.8× 37 0.5× 28 0.5× 23 461
Grace Liang United States 6 175 0.7× 67 0.4× 95 1.3× 30 0.4× 61 1.1× 9 444
Chin‐Han Wu Taiwan 9 103 0.4× 106 0.6× 90 1.3× 20 0.3× 40 0.7× 19 323
Dominik André‐Lévigne Switzerland 9 123 0.5× 67 0.4× 66 0.9× 26 0.4× 59 1.0× 14 309
Timothy E. Rayner Australia 11 135 0.6× 59 0.3× 99 1.4× 22 0.3× 75 1.3× 14 388
Dennis M. Ackerman United States 10 195 0.8× 90 0.5× 119 1.7× 14 0.2× 70 1.2× 14 507
Marcela Otranto Brazil 7 111 0.5× 75 0.4× 115 1.6× 25 0.4× 64 1.1× 9 484
Hamish Prosser Australia 14 173 0.7× 142 0.8× 226 3.1× 18 0.3× 216 3.8× 18 684
Gongchi Li China 10 206 0.9× 107 0.6× 117 1.6× 34 0.5× 76 1.3× 18 386

Countries citing papers authored by Karin Hehenberger

Since Specialization
Citations

This map shows the geographic impact of Karin Hehenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karin Hehenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karin Hehenberger more than expected).

Fields of papers citing papers by Karin Hehenberger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karin Hehenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karin Hehenberger. The network helps show where Karin Hehenberger may publish in the future.

Co-authorship network of co-authors of Karin Hehenberger

This figure shows the co-authorship network connecting the top 25 collaborators of Karin Hehenberger. A scholar is included among the top collaborators of Karin Hehenberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karin Hehenberger. Karin Hehenberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Hehenberger, Karin. (2019). Patient Entrepreneurs to Drive Health Care Innovation for Kidney Disease. Clinical Journal of the American Society of Nephrology. 14(2). 288–290. 1 indexed citations
2.
3.
Hehenberger, Karin, Gunnar Kratz, Anders Hansson, & Kerstin Brismar. (1998). Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. Journal of Dermatological Science. 16(2). 144–151. 73 indexed citations
4.
Hehenberger, Karin, Johan Heilborn, Kerstin Brismar, & Anders Hansson. (1998). Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of L‐lactate. Wound Repair and Regeneration. 6(2). 135–141. 128 indexed citations
5.
Hehenberger, Karin & Anders Hansson. (1997). High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochemistry and Function. 15(3). 197–201. 61 indexed citations
6.
Hehenberger, Karin, Kerstin Brismar, Folke Lind, & Gunnar Kratz. (1997). Dose‐dependent hyperbaric oxygen stimulation of human fibroblast proliferation. Wound Repair and Regeneration. 5(2). 147–150. 64 indexed citations
7.
Hehenberger, Karin & Anders Hansson. (1997). High glucose‐induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochemistry and Function. 15(3). 197–201. 8 indexed citations
8.
Hansson, Anders, Karin Hehenberger, & Marja Thorén. (1996). Long‐term treatment of swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin‐like growth factor‐I (IGF‐I). Cell Biochemistry and Function. 14(2). 121–129. 17 indexed citations
9.
Hansson, Anders, et al.. (1996). Long‐Term Treatment of Swiss 3T3 Fibroblasts with Dexamethasone Attenuates MAP Kinase Activation Induced by Insulin‐Like Growth Factor‐I (IGF‐I). Cell Biochemistry and Function. 14(2). 121–129. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ariana García‐Ojalvo Breakdown of academic impact, for papers by Guojuan Lao Breakdown of academic impact, for papers by Grace Liang Breakdown of academic impact, for papers by Chin‐Han Wu Breakdown of academic impact, for papers by Dominik André‐Lévigne Breakdown of academic impact, for papers by Timothy E. Rayner Breakdown of academic impact, for papers by Dennis M. Ackerman Breakdown of academic impact, for papers by Marcela Otranto Breakdown of academic impact, for papers by Hamish Prosser Breakdown of academic impact, for papers by Gongchi Li
Rankless by CCL
2026